文献速递心境障碍精神分裂症与精神病性障碍儿童青少年精神

SARS-CoV-2感染后神经与精神风险轨迹:两年回顾性队列分析

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
PubMed 文献 · Lancet Psychiatry · 2022-08-17

该研究基于TriNetX电子健康记录网络,纳入1 284 437例COVID-19患者并与其他呼吸道感染患者1:1倾向匹配,评估14种神经与精神诊断的2年风险轨迹。结果显示心境与焦虑障碍风险短暂升高后回归基线,而精神病性障碍、认知缺陷、痴呆及癫痫或惊厥风险持续升高;儿童整体精神风险较成人温和但部分诊断风险持续。

要点

  • 心境障碍风险在43天回归基线,焦虑障碍在58天回归基线,后续总体发生率与匹配组相等。
  • 精神病性障碍、认知缺陷、痴呆及癫痫或惊厥风险在2年随访结束时仍升高。
  • 儿童在感染后6个月内心境与焦虑障碍风险未升高,但认知缺陷等部分诊断风险升高。

核心结论

  • COVID-19后心境与焦虑障碍发生率升高是短暂的,与其他呼吸道感染相比无总体超额诊断。
  • 精神病性障碍、认知缺陷、痴呆及癫痫或惊厥的升高风险持续贯穿2年随访。
  • 儿童整体精神风险轮廓较成人及老年人温和,但部分诊断持续较高风险值得关注。

研究设计与样本

  • COVID-19患者按1:1倾向评分匹配至同期其他呼吸道感染患者,匹配基于人口学、风险因素及疫苗接种状态。
  • 分析按年龄组(<18岁、18-64岁、≥65岁)及诊断日期分层,评估14种神经与精神诊断风险。

主要发现

  • 多数结局在6个月后HR显著大于1,但风险地平线与相等发生率时间差异很大。
  • 心境障碍风险在43天回归基线,焦虑障碍在58天回归基线;总体发生率相等时间分别为457天和417天。
  • 儿童感染后6个月内心境障碍HR 1·02(95%CI 0·94-1·10)、焦虑障碍HR 1·00(95%CI 0·94-1·06),无升高风险。
  • 儿童认知缺陷、失眠、颅内出血、缺血性卒中、神经/神经根/ plexus障碍、精神病性障碍及癫痫或惊厥风险升高,HR范围1·20(1·09-1·33)至2·16(1·46-3·19)。
  • 儿童认知缺陷风险地平线为75天,相等发生率时间为491天。

关键数值与推荐

  • Alpha变异出现前后风险轮廓相似(每队列n=47 675)。
  • Delta变异出现后较之前,缺血性卒中、癫痫或惊厥、认知缺陷、失眠及焦虑障碍风险升高,并伴有死亡率升高(每队列n=44 835)。
  • Omicron变异出现后较之前,死亡率较低,但神经与精神结局风险保持相似(每队列n=39 845)。

临床怎么用

  • 应关注COVID-19后持续升高的精神病性障碍、认知缺陷、痴呆及癫痫或惊厥风险。
  • 儿童感染后需关注认知缺陷、失眠、精神病性障碍及癫痫或惊厥等部分诊断的持续风险。
  • Delta与Omicron变异期间神经与精神结局相似,提示医疗系统负担可能持续。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 is associated with increased risks of neurological and psychiatric sequelae in the weeks and months thereafter. How long these risks remain, whether they affect children and adults similarly, and whether SARS-CoV-2 variants differ in their risk profiles remains unclear. METHODS: In this analysis of 2-year retrospective cohort studies, we extracted data from the TriNetX electronic health records network, an international network of de-identified data from health-care records of approximately 89 million patients collected from hospital, primary care, and specialist providers (mostly from the USA, but also from Australia, the UK, Spain, Bulgaria, India, Malaysia, and Taiwan). A cohort of patients of any age with COVID-19 diagnosed between Jan 20, 2020, and April 13, 2022, was identified and propensity-score matched (1:1) to a contemporaneous cohort of patients with any other respiratory infection. Matching was done on the basis of demographic factors, risk factors for COVID-19 and severe COVID-19 illness, and vaccination status. Analyses were stratified by age group (age <18 years [children], 18-64 years [adults], and ≥65 years [older adults]) and date of diagnosis. We assessed the risks of 14 neurological and psychiatric diagnoses after SARS-CoV-2 infection and compared these risks with the matched comparator cohort. The 2-year risk trajectories were represented by time-varying hazard ratios (HRs) and summarised using the 6-month constant HRs (representing the risks in the earlier phase of follow-up, which have not yet been well characterised in children), the risk horizon for each outcome (ie, the time at which the HR returns to 1), and the time to equal incidence in the two cohorts. We also estimated how many people died after a neurological or psychiatric diagnosis during follow-up in each age group. Finally, we compared matched cohorts of patients diagnosed with COVID-19 directly before and after the emergence of the alpha (B.1.1.7), delta (B.1.617.2), and omicron (B.1.1.529) variants. FINDINGS: We identified 1 487 712 patients with a recorded diagnosis of COVID-19 during the study period, of whom 1 284 437 (185 748 children, 856 588 adults, and 242 101 older adults; overall mean age 42·5 years [SD 21·9]; 741 806 [57·8%] were female and 542 192 [42·2%] were male) were adequately matched with an equal number of patients with another respiratory infection. The risk trajectories of outcomes after SARS-CoV-2 infection in the whole cohort differed substantially. While most outcomes had HRs significantly greater than 1 after 6 months (with the exception of encephalitis; Guillain-Barré syndrome; nerve, nerve root, and plexus disorder; and parkinsonism), their risk horizons and time to equal incidence varied greatly. Risks of the common psychiatric disorders returned to baseline after 1-2 months (mood disorders at 43 days, anxiety disorders at 58 days) and subsequently reached an equal overall incidence to the matched comparison group (mood disorders at 457 days, anxiety disorders at 417 days). By contrast, risks of cognitive deficit (known as brain fog), dementia, psychotic disorders, and epilepsy or seizures were still increased at the end of the 2-year follow-up period. Post-COVID-19 risk trajectories differed in children compared with adults: in the 6 months after SARS-CoV-2 infection, children were not at an increased risk of mood (HR 1·02 [95% CI 0·94-1·10) or anxiety (1·00 [0·94-1·06]) disorders, but did have an increased risk of cognitive deficit, insomnia, intracranial haemorrhage, ischaemic stroke, nerve, nerve root, and plexus disorders, psychotic disorders, and epilepsy or seizures (HRs ranging from 1·20 [1·09-1·33] to 2·16 [1·46-3·19]). Unlike adults, cognitive deficit in children had a finite risk horizon (75 days) and a finite time to equal incidence (491 days). A sizeable proportion of older adults who received a neurological or psychiatric diagnosis, in either cohort, subsequently died, especially those diagnosed with dementia or epilepsy or seizures. Risk profiles were similar just before versus just after the emergence of the alpha variant (n=47 675 in each cohort). Just after (vs just before) the emergence of the delta variant (n=44 835 in each cohort), increased risks of ischaemic stroke, epilepsy or seizures, cognitive deficit, insomnia, and anxiety disorders were observed, compounded by an increased death rate. With omicron (n=39 845 in each cohort), there was a lower death rate than just before emergence of the variant, but the risks of neurological and psychiatric outcomes remained similar. INTERPRETATION: This analysis of 2-year retrospective cohort studies of individuals diagnosed with COVID-19 showed that the increased incidence of mood and anxiety disorders was transient, with no overall excess of these diagnoses compared with other respiratory infections. In contrast, the increased risk of psychotic disorder, cognitive deficit, dementia, and epilepsy or seizures persisted throughout. The differing trajectories suggest a different pathogenesis for these outcomes. Children have a more benign overall profile of psychiatric risk than do adults and older adults, but their sustained higher risk of some diagnoses is of concern. The fact that neurological and psychiatric outcomes were similar during the delta and omicron waves indicates that the burden on the health-care system might continue even with variants that are less severe in other respects. Our findings are relevant to understanding individual-level and population-level risks of neurological and psychiatric disorders after SARS-CoV-2 infection and can help inform our responses to them. FUNDING: National Institute for Health and Care Research Oxford Health Biomedical Research Centre, The Wolfson Foundation, and MQ Mental Health Research.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022. PMID: 35987197. doi:10.1016/S2215-0366(22)00260-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。